Pluviaendo Visuals Pluviaendo Visuals

X

CAS 1228879-37-5 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 1228879-37-5
Also known as: 1228879-37-5, 1-benzyl-4-methyl-3-(methylamino)piperidine dihydrochloride, Mfcd09475546, 1-benzyl-n,4-dimethylpiperidin-3-amine;dihydrochloride, 3-piperidinamine, n,4-dimethyl-1-(phenylmethyl)-, hydrochloride (1:2), Tofacitinib impurity 02
Molecular Formula
C14H24Cl2N2
Molecular Weight
291.3  g/mol
InChI Key
CVQNXCBXFOIHLH-UHFFFAOYSA-N

1 2D Structure

CAS 1228879-37-5

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-benzyl-N,4-dimethylpiperidin-3-amine;dihydrochloride
2.1.2 InChI
InChI=1S/C14H22N2.2ClH/c1-12-8-9-16(11-14(12)15-2)10-13-6-4-3-5-7-13;;/h3-7,12,14-15H,8-11H2,1-2H3;2*1H
2.1.3 InChI Key
CVQNXCBXFOIHLH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1CCN(CC1NC)CC2=CC=CC=C2.Cl.Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 1228879-37-5

2. 1-benzyl-4-methyl-3-(methylamino)piperidine Dihydrochloride

3. Mfcd09475546

4. 1-benzyl-n,4-dimethylpiperidin-3-amine;dihydrochloride

5. 3-piperidinamine, N,4-dimethyl-1-(phenylmethyl)-, Hydrochloride (1:2)

6. Tofacitinib Impurity 02

7. Tofacitinib Impurity F

8. Mfcd09864744

9. 477600-68-3

10. Schembl1847744

11. Cs-m3092

12. Akos025290698

13. Am85514

14. Sb10188

15. Sb20814

16. Sb22747

17. Ac-31054

18. Cs-13048

19. Sy008371

20. Sy026946

21. Db-059460

22. Ft-0648996

23. A910075

24. N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine 2hcl

25. 1-benzyl-4-methyl-3-(methylamino)piperidinedihydrochloride

26. (1-benzyl-4-methylpiperidin-3-yl)-methylamine Bishydrochloride

27. (1-benzyl4-methylpiperidin-3-yl)-methylamine Bishydrochloride

28. (1-benzyl-4-methyl-piperidin-3-yl)-methyl-amine Dihydrochloride

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 291.3 g/mol
Molecular Formula C14H24Cl2N2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count2
Rotatable Bond Count3
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area15.3
Heavy Atom Count18
Formal Charge0
Complexity199
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
Flag China
Digital Content Digital Content
3680-69-1
Tofacitinib Citrate
Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and ...
Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming to global API standards, along with professional R&D and marketing teams, Hengkang’s operations span major pharmaceutical markets such as China, Europe, the CIS region, Japan, and South Korea. Hengkang has established long-term and stable relationships with nearly 70 countries overseas and hundreds of domestic enterprises.
Flag China
Digital Content Digital Content
1062580-52-2
Tofacitinib Citrate
Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and ...
Established in 2004 and headquartered in Hangzhou, Hengkang established multiple factories, research and sales centers in Zhejiang, Shandong, and Henan. With facilities conforming to global API standards, along with professional R&D and marketing teams, Hengkang’s operations span major pharmaceutical markets such as China, Europe, the CIS region, Japan, and South Korea. Hengkang has established long-term and stable relationships with nearly 70 countries overseas and hundreds of domestic enterprises.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY